Literature DB >> 7606778

Induction of anti-self-immunity to cure cancer.

N K Nanda1, E E Sercarz.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7606778     DOI： 10.1016/0092-8674(95)90047-0

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  43 in total

Review 1.  Anti-HER2 vaccines: new prospects for breast cancer therapy.

Authors:  Maha Zohra Ladjemi; William Jacot; Thierry Chardès; André Pèlegrin; Isabelle Navarro-Teulon
Journal:  Cancer Immunol Immunother       Date:  2010-06-08       Impact factor: 6.968

2.  Inducing autoimmune disease to treat cancer.

Authors:  D M Pardoll
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 3.  Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.

Authors:  Maurizio Zanetti; Xavier Hernandez; Pierre Langlade-Demoyen
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

Review 4.  T-cell recognition of self peptides as tumor rejection antigens.

Authors:  Y Kawakami; S A Rosenberg
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.

Authors:  C Liu; J Goldstein; R F Graziano; J He; J K O'Shea; Y Deo; P M Guyre
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Authors:  Wolfgang Dummer; Andreas G Niethammer; Roberto Baccala; Brian R Lawson; Norbert Wagner; Ralph A Reisfeld; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells.

Authors:  J M Corman; E E Sercarz; N K Nanda
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

Authors:  J Roth; D Dittmer; D Rea; J Tartaglia; E Paoletti; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 10.  Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2014-08       Impact factor: 11.151
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.